Stephanie A Eucker, Oliver Glass, Mitchell R Knisely, Amy O'Regan, Christi De Larco, Michelle Mill, Austin Dixon, Morgan Sill Henis, Erica Walker, Alexander Gordee, Shein-Chung Chow, Maggie Kuchibhatla
Background: Acute musculoskeletal pain in emergency department (ED) patients is challenging to treat with medications alone, but adding acupuncture may improve pain outcomes.
Methods: In this pragmatic randomized controlled trial, acupuncture was delivered by licensed acupuncturists in the ED and twice a week in follow-up clinic for 1 month. From February 10, 2020 to April 19, 2023, 2781 adult patients at an academic ED with acute (≤7 days) musculoskeletal pain in neck, back and/or extremities were screened, and 599 were enrolled and randomized to usual care only (n = 189, 31.6%) or acupuncture plus usual care (n = 410, 68.4%).
Results: Acupuncture and control arms had similar demographics (mean age 45.2, SD 15.8; 57.7% female) and baseline pain scores (control 7.1, SD 2.2; acupuncture 7.1, SD 2.3). At 1 month, pain scores were similar between arms (control 3.8, SD 3.2; acupuncture 3.2, SD 3.0). However, 178 (43.4%) participants in the acupuncture arm were unable to attend acupuncture clinic and reported time and financial constraints. Exploratory analysis of pain score by number of clinic sessions attended showed that patients attending 6 or more acupuncture sessions (n = 121, 20.2%) experienced significant pain improvements compared to those with fewer sessions (n = 478, 79.8%).
Conclusion: Improving access and availability of acupuncture in outpatient settings may be needed for more effective pain management.
{"title":"Acupuncture for Acute Musculoskeletal Pain in the Emergency Department and Clinic: A Pragmatic Randomized Trial.","authors":"Stephanie A Eucker, Oliver Glass, Mitchell R Knisely, Amy O'Regan, Christi De Larco, Michelle Mill, Austin Dixon, Morgan Sill Henis, Erica Walker, Alexander Gordee, Shein-Chung Chow, Maggie Kuchibhatla","doi":"10.1093/pm/pnaf165","DOIUrl":"https://doi.org/10.1093/pm/pnaf165","url":null,"abstract":"<p><strong>Background: </strong>Acute musculoskeletal pain in emergency department (ED) patients is challenging to treat with medications alone, but adding acupuncture may improve pain outcomes.</p><p><strong>Methods: </strong>In this pragmatic randomized controlled trial, acupuncture was delivered by licensed acupuncturists in the ED and twice a week in follow-up clinic for 1 month. From February 10, 2020 to April 19, 2023, 2781 adult patients at an academic ED with acute (≤7 days) musculoskeletal pain in neck, back and/or extremities were screened, and 599 were enrolled and randomized to usual care only (n = 189, 31.6%) or acupuncture plus usual care (n = 410, 68.4%).</p><p><strong>Results: </strong>Acupuncture and control arms had similar demographics (mean age 45.2, SD 15.8; 57.7% female) and baseline pain scores (control 7.1, SD 2.2; acupuncture 7.1, SD 2.3). At 1 month, pain scores were similar between arms (control 3.8, SD 3.2; acupuncture 3.2, SD 3.0). However, 178 (43.4%) participants in the acupuncture arm were unable to attend acupuncture clinic and reported time and financial constraints. Exploratory analysis of pain score by number of clinic sessions attended showed that patients attending 6 or more acupuncture sessions (n = 121, 20.2%) experienced significant pain improvements compared to those with fewer sessions (n = 478, 79.8%).</p><p><strong>Conclusion: </strong>Improving access and availability of acupuncture in outpatient settings may be needed for more effective pain management.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145654537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Editorial Commentary: Bridging evidence and practice in sacroiliac joint complex pain management.","authors":"Elias Veizi, David M Dickerson, Ameet S Nagpal","doi":"10.1093/pm/pnaf134","DOIUrl":"10.1093/pm/pnaf134","url":null,"abstract":"","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":"815-816"},"PeriodicalIF":3.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145636600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zachary L McCormick, Robert W Hurley, Steven P Cohen
{"title":"Sacroiliac joint complex pain consensus practice guidelines from a multispecialty, international working group: an infographic.","authors":"Zachary L McCormick, Robert W Hurley, Steven P Cohen","doi":"10.1093/pm/pnaf136","DOIUrl":"10.1093/pm/pnaf136","url":null,"abstract":"","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":"936-937"},"PeriodicalIF":3.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12681189/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145637164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Peter D Vu, Matthew Slitzky, Kobe Miller, Robert J Yong, Christopher L Robinson, Matthew Chung
Background: Magnetic resonance imaging (MRI) safety with implanted neuromodulation devices presents a critical challenge in modern medicine. While spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) devices are increasingly utilized for pain management, the scattered nature of manufacturer-specific MRI safety information creates substantial challenges for healthcare providers in making informed clinical decisions. Furthermore, despite the public availability of this information, a comprehensive review of the literature reveals no centralized repository of data regarding SCS and PNS.
Objective: To synthesize comprehensive MRI safety data from multiple manufacturers of SCS and PNS devices into a centralized resource for clinicians, thereby streamlining the decision-making process for MRI scanning in patients with implanted neuromodulation devices.
Methods: We collected MRI safety data for devices from 10 major neurostimulation companies (Abbott, Biotronik, Boston Scientific, Curonix, Mainstay, Medtronic, Nalu, Nevro, Saluda, and SPR Therapeutics) through December 2024. Data collection involved direct communication with manufacturers and analysis of technical documentation to extract specific MRI-related parameters.
Results: Full-body MRI safety at 1.5 T is standard across most SCS systems, with select devices permitting 3.0 T imaging. Specific limitations vary by manufacturer, including restrictions on spatial gradient magnetic fields (1000-4000 Gauss/cm), specific absorption rates, and active scan times (15-60 minutes). PNS systems show similar safety patterns.
Conclusions: This manuscript addresses the urgent need for centralized safety information. As device technology continues to evolve, this resource will require ongoing updates to maintain its utility in supporting informed clinical decision making and patient care.
{"title":"Provision of up-to-date magnetic resonance imaging conditionality for current peripheral nerve stimulation and spinal cord stimulation systems in pain management.","authors":"Peter D Vu, Matthew Slitzky, Kobe Miller, Robert J Yong, Christopher L Robinson, Matthew Chung","doi":"10.1093/pm/pnaf076","DOIUrl":"10.1093/pm/pnaf076","url":null,"abstract":"<p><strong>Background: </strong>Magnetic resonance imaging (MRI) safety with implanted neuromodulation devices presents a critical challenge in modern medicine. While spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) devices are increasingly utilized for pain management, the scattered nature of manufacturer-specific MRI safety information creates substantial challenges for healthcare providers in making informed clinical decisions. Furthermore, despite the public availability of this information, a comprehensive review of the literature reveals no centralized repository of data regarding SCS and PNS.</p><p><strong>Objective: </strong>To synthesize comprehensive MRI safety data from multiple manufacturers of SCS and PNS devices into a centralized resource for clinicians, thereby streamlining the decision-making process for MRI scanning in patients with implanted neuromodulation devices.</p><p><strong>Methods: </strong>We collected MRI safety data for devices from 10 major neurostimulation companies (Abbott, Biotronik, Boston Scientific, Curonix, Mainstay, Medtronic, Nalu, Nevro, Saluda, and SPR Therapeutics) through December 2024. Data collection involved direct communication with manufacturers and analysis of technical documentation to extract specific MRI-related parameters.</p><p><strong>Results: </strong>Full-body MRI safety at 1.5 T is standard across most SCS systems, with select devices permitting 3.0 T imaging. Specific limitations vary by manufacturer, including restrictions on spatial gradient magnetic fields (1000-4000 Gauss/cm), specific absorption rates, and active scan times (15-60 minutes). PNS systems show similar safety patterns.</p><p><strong>Conclusions: </strong>This manuscript addresses the urgent need for centralized safety information. As device technology continues to evolve, this resource will require ongoing updates to maintain its utility in supporting informed clinical decision making and patient care.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":"924-929"},"PeriodicalIF":3.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144529209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jacqueline Weisbein, Denis Patterson, Douglas Beall, Dan Nguyen, Jack Smith, Caroline Harstroem, Timothy Davis, Jeffrey Foster, Anne Christopher, Daniel Kloster, John Broadnax, Eric Anderson, John Hatheway, Andrew Trobridge, Charles Simmons, Thomas Stauss, Michael Harned, Christopher Mallard
Purpose: Sacroiliac joint (SIJ) pain, a frequent contributor to low back pain, is commonly treated with minimally invasive SIJ fusion. A large body of evidence supports the safety and effectiveness of lateral transiliac SIJ fusion. Traditionally performed by surgeons, this procedure is increasing in utilization by non-surgeon interventionalists. Herein, we present early safety results from a single-arm clinical trial of participants who underwent lateral SIJ fusion using threaded titanium implants placed by interventional pain management physicians.
Methods: STACI (NCT05870488) is a 2-year prospective study conducted at 15 US interventional pain management sites. The primary endpoint is change in SIJ pain from baseline to 6 months. Secondary endpoints include changes in function (Oswestry Disability Index), quality of life (PROMIS-29), device- or procedure-related adverse events, and evidence of fusion on CT scan at 2 years.
Results: A total of 110 patients were enrolled. Mean (SD) participant age is 64 (14) years and 68% are female. Mean (SD) operative time was 44 minutes (16) and estimated blood loss was 14 cc (15). No serious or device-related adverse events have occurred. Reported perioperative adverse events include one surgical site infection and one hematoma. At 1-month follow-up, ODI improved by 18 points (P < .0001) and SIJ pain (NRS) decreased by 4 points (P < .0001) from baseline.
Conclusion: Early results from this prospective multicenter study support the relative safety and early effectiveness of LTI SIJ fusion using a threaded implant when performed by interventional pain management physicians. The data are consistent with published literature with a low adverse event rate and early improvements in pain and function.
{"title":"Safety and initial effectiveness of minimally invasive sacroiliac joint fusion with metal implants using a lateral transiliac approach: a prospective trial.","authors":"Jacqueline Weisbein, Denis Patterson, Douglas Beall, Dan Nguyen, Jack Smith, Caroline Harstroem, Timothy Davis, Jeffrey Foster, Anne Christopher, Daniel Kloster, John Broadnax, Eric Anderson, John Hatheway, Andrew Trobridge, Charles Simmons, Thomas Stauss, Michael Harned, Christopher Mallard","doi":"10.1093/pm/pnaf082","DOIUrl":"10.1093/pm/pnaf082","url":null,"abstract":"<p><strong>Purpose: </strong>Sacroiliac joint (SIJ) pain, a frequent contributor to low back pain, is commonly treated with minimally invasive SIJ fusion. A large body of evidence supports the safety and effectiveness of lateral transiliac SIJ fusion. Traditionally performed by surgeons, this procedure is increasing in utilization by non-surgeon interventionalists. Herein, we present early safety results from a single-arm clinical trial of participants who underwent lateral SIJ fusion using threaded titanium implants placed by interventional pain management physicians.</p><p><strong>Methods: </strong>STACI (NCT05870488) is a 2-year prospective study conducted at 15 US interventional pain management sites. The primary endpoint is change in SIJ pain from baseline to 6 months. Secondary endpoints include changes in function (Oswestry Disability Index), quality of life (PROMIS-29), device- or procedure-related adverse events, and evidence of fusion on CT scan at 2 years.</p><p><strong>Results: </strong>A total of 110 patients were enrolled. Mean (SD) participant age is 64 (14) years and 68% are female. Mean (SD) operative time was 44 minutes (16) and estimated blood loss was 14 cc (15). No serious or device-related adverse events have occurred. Reported perioperative adverse events include one surgical site infection and one hematoma. At 1-month follow-up, ODI improved by 18 points (P < .0001) and SIJ pain (NRS) decreased by 4 points (P < .0001) from baseline.</p><p><strong>Conclusion: </strong>Early results from this prospective multicenter study support the relative safety and early effectiveness of LTI SIJ fusion using a threaded implant when performed by interventional pain management physicians. The data are consistent with published literature with a low adverse event rate and early improvements in pain and function.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":"918-923"},"PeriodicalIF":3.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144507326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zachary L McCormick, Robert W Hurley, Magdalena Anitescu, Arun Bhaskar, Anuj Bhatia, Ryan Carter Cassidy, Allen S Chen, Timothy C Dawson, Javier De Andrés Ares, José Luiz de Campos, Salim M Hayek, Berenice Carolina Hernández-Porras, Narayan R Kissoon, Lynn R Kohan, María Francisca Elgueta Le Beuffe, Jee Youn Moon, David A Provenzano, David E Reece, Nathaniel M Schuster, Clark C Smith, Alison Stout, Karolina Szadek, Donna-Ann Thomas, Nuj Tontisirin, Michael F Vagg, Jan Van Zundert, Anna Woodbury, Steven P Cohen
<p><strong>Background: </strong>The past two decades have witnessed tremendous growth in the appreciation and treatment of sacroiliac joint (SIJ) complex pain, including anatomical dissections that shed light on innervation, an appreciation for the contribution of extra-articular components to SIJ complex pain, the advent of radiofrequency ablation (RFA) and a host of minimally invasive surgical techniques. Yet, there is no standardization on diagnosis and treatment paradigms.</p><p><strong>Methods: </strong>In February 2023, the Boards of Directors for the American Academy of Pain Medicine (AAPM) and American Society of Regional Anesthesia & Pain Medicine (ASRA-PM) approved the development of multispecialty guidelines on SIJ complex pain. Thirty partner organizations with clinical and scientific interests in SIJ complex pain were identified, and formal letters of request-for-participation were sent to each, along with a request for nominees to serve on the committee. Twenty five organizations agreed to participate in addition to the Departments of Defense and Veterans Affairs. A steering committee developed 21 questions, which spanned criteria for diagnosis, non-interventional and interventional treatments including surgery, technical parameters on how to optimize results, and what constitutes positive outcomes. Questions were methodically assigned to specialized modules comprising 4-5 members with complementary expertise, who collaborated with the Subcommittee Lead and one of three Committee Chairs to develop preliminary drafts. Following thorough revisions, these drafts were subsequently submitted to the full committee for comprehensive review. A modified Delphi method was used in which the answers to questions were sent to the committee en bloc and comments were returned in a non-blinded fashion to the Chairs, who incorporated the comments and sent out revised versions until consensus was achieved. During a committee meeting before commencement, it was agreed that recommendations would be noted when there was >50% agreement among committee members, but that a formal recommendation would require ≥75% consensus.</p><p><strong>Results: </strong>Twenty-one organizations formally endorsed the guidelines. The American Society of Anesthesiologists, and American Academy of Physical Medicine & Rehabilitation, and the North American Spine Society affirmed the benefit of the guidelines but did not officially endorse them. The American Academy of Neurology declined to affirm the benefit of the guidelines citing "lack of relevance to their membership." Per policies, while the Departments of Defense and Veterans Affairs did not formally review the guidelines for endorsement, their representatives approved them. In addition to being endorsed or the benefit affirmed by all voting organizations, complete consensus from committee members was obtained on all 21 questions. On 2 recommendations, there were dissensions from 3 societies who thought that selecting p
{"title":"Consensus practice guidelines on sacroiliac joint complex pain from a multispecialty, international working group.","authors":"Zachary L McCormick, Robert W Hurley, Magdalena Anitescu, Arun Bhaskar, Anuj Bhatia, Ryan Carter Cassidy, Allen S Chen, Timothy C Dawson, Javier De Andrés Ares, José Luiz de Campos, Salim M Hayek, Berenice Carolina Hernández-Porras, Narayan R Kissoon, Lynn R Kohan, María Francisca Elgueta Le Beuffe, Jee Youn Moon, David A Provenzano, David E Reece, Nathaniel M Schuster, Clark C Smith, Alison Stout, Karolina Szadek, Donna-Ann Thomas, Nuj Tontisirin, Michael F Vagg, Jan Van Zundert, Anna Woodbury, Steven P Cohen","doi":"10.1093/pm/pnaf129","DOIUrl":"10.1093/pm/pnaf129","url":null,"abstract":"<p><strong>Background: </strong>The past two decades have witnessed tremendous growth in the appreciation and treatment of sacroiliac joint (SIJ) complex pain, including anatomical dissections that shed light on innervation, an appreciation for the contribution of extra-articular components to SIJ complex pain, the advent of radiofrequency ablation (RFA) and a host of minimally invasive surgical techniques. Yet, there is no standardization on diagnosis and treatment paradigms.</p><p><strong>Methods: </strong>In February 2023, the Boards of Directors for the American Academy of Pain Medicine (AAPM) and American Society of Regional Anesthesia & Pain Medicine (ASRA-PM) approved the development of multispecialty guidelines on SIJ complex pain. Thirty partner organizations with clinical and scientific interests in SIJ complex pain were identified, and formal letters of request-for-participation were sent to each, along with a request for nominees to serve on the committee. Twenty five organizations agreed to participate in addition to the Departments of Defense and Veterans Affairs. A steering committee developed 21 questions, which spanned criteria for diagnosis, non-interventional and interventional treatments including surgery, technical parameters on how to optimize results, and what constitutes positive outcomes. Questions were methodically assigned to specialized modules comprising 4-5 members with complementary expertise, who collaborated with the Subcommittee Lead and one of three Committee Chairs to develop preliminary drafts. Following thorough revisions, these drafts were subsequently submitted to the full committee for comprehensive review. A modified Delphi method was used in which the answers to questions were sent to the committee en bloc and comments were returned in a non-blinded fashion to the Chairs, who incorporated the comments and sent out revised versions until consensus was achieved. During a committee meeting before commencement, it was agreed that recommendations would be noted when there was >50% agreement among committee members, but that a formal recommendation would require ≥75% consensus.</p><p><strong>Results: </strong>Twenty-one organizations formally endorsed the guidelines. The American Society of Anesthesiologists, and American Academy of Physical Medicine & Rehabilitation, and the North American Spine Society affirmed the benefit of the guidelines but did not officially endorse them. The American Academy of Neurology declined to affirm the benefit of the guidelines citing \"lack of relevance to their membership.\" Per policies, while the Departments of Defense and Veterans Affairs did not formally review the guidelines for endorsement, their representatives approved them. In addition to being endorsed or the benefit affirmed by all voting organizations, complete consensus from committee members was obtained on all 21 questions. On 2 recommendations, there were dissensions from 3 societies who thought that selecting p","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":"817-917"},"PeriodicalIF":3.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12681192/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145636632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eyal D Maoz Halevy, Allison Verhaak, Yin Wu, Dale S Bond, Lucas J Carr, Brian Grosberg, Olivia Begasse de Dhaem
{"title":"Evaluating Physical Activity Levels in Patients with Migraine: Insights from a Tertiary Headache Center Using the Exercise Vital Sign (EVS) Tool.","authors":"Eyal D Maoz Halevy, Allison Verhaak, Yin Wu, Dale S Bond, Lucas J Carr, Brian Grosberg, Olivia Begasse de Dhaem","doi":"10.1093/pm/pnaf166","DOIUrl":"https://doi.org/10.1093/pm/pnaf166","url":null,"abstract":"","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145605389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amanda S Bruce, Tara M D Mullen, Megan Behrman, Jade Robichaud, Ruobin Wei, Nivedita Chaudhary, Anna M Georgiopoulos, Lael M Yonker, Jianghua He, Andrea L Chadwick, Jonathan Greenberg, Deborah Friedman
Background: Despite treatment advances, the majority of adults with cystic fibrosis (CF) experience chronic pain, negatively impacting quality of life. CF Foundation guidelines call for a multi-modal approach to pain management. While non-pharmacologic behavioral interventions are an effective and safe component of such an approach, there are no existing behavioral interventions that have been designed specifically for adults with CF who experience chronic pain.
Objective: We created a novel cognitive-behavioral and mind-body intervention tailored to the needs, preferences, and experiences of adults with CF and chronic pain.
Methods: Individual qualitative interviews were conducted with 14 adults with CF and chronic pain. A hybrid inductive-deductive thematic analysis was conducted to identify themes regarding needs and preferences to inform intervention development.
Results: We identified the following themes: 1) the importance of addressing mental health, 2) need for an individualized/tailored program, 3) preference for CF care team delivery, 4) CF-specific modifications of proposed content, 5) barriers and facilitators of patient engagement with a mind-body pain management intervention in CF.
Discussion: Adults with CF provided vital feedback on the structure and substance of a cognitive-behavioral and mind-body intervention for chronic pain, which was utilized to create the Pain Acknowledgement, Coping, and Empowerment (PACE CF), a program to be delivered as part of routine care in CF centers.
{"title":"Patient-centered development of a cognitive behavioral pain intervention for cystic fibrosis: The pace CF program.","authors":"Amanda S Bruce, Tara M D Mullen, Megan Behrman, Jade Robichaud, Ruobin Wei, Nivedita Chaudhary, Anna M Georgiopoulos, Lael M Yonker, Jianghua He, Andrea L Chadwick, Jonathan Greenberg, Deborah Friedman","doi":"10.1093/pm/pnaf167","DOIUrl":"https://doi.org/10.1093/pm/pnaf167","url":null,"abstract":"<p><strong>Background: </strong>Despite treatment advances, the majority of adults with cystic fibrosis (CF) experience chronic pain, negatively impacting quality of life. CF Foundation guidelines call for a multi-modal approach to pain management. While non-pharmacologic behavioral interventions are an effective and safe component of such an approach, there are no existing behavioral interventions that have been designed specifically for adults with CF who experience chronic pain.</p><p><strong>Objective: </strong>We created a novel cognitive-behavioral and mind-body intervention tailored to the needs, preferences, and experiences of adults with CF and chronic pain.</p><p><strong>Methods: </strong>Individual qualitative interviews were conducted with 14 adults with CF and chronic pain. A hybrid inductive-deductive thematic analysis was conducted to identify themes regarding needs and preferences to inform intervention development.</p><p><strong>Results: </strong>We identified the following themes: 1) the importance of addressing mental health, 2) need for an individualized/tailored program, 3) preference for CF care team delivery, 4) CF-specific modifications of proposed content, 5) barriers and facilitators of patient engagement with a mind-body pain management intervention in CF.</p><p><strong>Discussion: </strong>Adults with CF provided vital feedback on the structure and substance of a cognitive-behavioral and mind-body intervention for chronic pain, which was utilized to create the Pain Acknowledgement, Coping, and Empowerment (PACE CF), a program to be delivered as part of routine care in CF centers.</p>","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145582291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rena Elizabeth Courtney, Jody Caretti, Jessica Dunham, Laura Curry, Stephanie Smith, Camden O Novikova
{"title":"Anti-Inflammatory Kitchen: Feasibility and Acceptability of a Cooking Demonstration Class for Veterans with Chronic Pain.","authors":"Rena Elizabeth Courtney, Jody Caretti, Jessica Dunham, Laura Curry, Stephanie Smith, Camden O Novikova","doi":"10.1093/pm/pnaf164","DOIUrl":"https://doi.org/10.1093/pm/pnaf164","url":null,"abstract":"","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145564890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yun-Yun K Chen, Jenna M Wilson, Sheila R Gokul, Patrick W Collins, Martin Kiik, Emily Rosado, Kamen V Vlassakov, Kristin L Schreiber
{"title":"When Clinical Intuition Fails: Exploration of Clinicians' Underrecognition of Preoperative Pain Catastrophizing Despite Direct Observation.","authors":"Yun-Yun K Chen, Jenna M Wilson, Sheila R Gokul, Patrick W Collins, Martin Kiik, Emily Rosado, Kamen V Vlassakov, Kristin L Schreiber","doi":"10.1093/pm/pnaf158","DOIUrl":"https://doi.org/10.1093/pm/pnaf158","url":null,"abstract":"","PeriodicalId":19744,"journal":{"name":"Pain Medicine","volume":" ","pages":""},"PeriodicalIF":3.0,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145549754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号